Literature DB >> 17901071

Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation.

Jing Zheng1, Yunxia Wen, Yang Song, Kai Wang, Dong-Bao Chen, Ronald R Magness.   

Abstract

Fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF) are two key regulators of placental angiogenesis. The potent vasodilator nitric oxide (NO) could also act as a key mediator of FGF2- and VEGF-induced angiogenesis. However, the postreceptor signaling pathways governing these FGF2- and VEGF-induced placental angiogenic responses are poorly understood. In this study, we assessed the role of endogenous NO, mitogen-activated protein kinase 3/1 (MAPK3/1), and v-akt murine thymoma viral oncogene homolog 1 (AKT1) in FGF2- and VEGF-stimulated proliferation of ovine fetoplacental endothelial (OFPAE) cells. Both FGF2 and VEGF time-dependently stimulated (P < 0.05) NO production and activated AKT1. Both FGF2- and VEGF-stimulated cell proliferation was dose-dependently inhibited (P < 0.05) by N(G)-monomethyl-L-arginine (L-NMMA; an NO synthase inhibitor), PD98059 (a selective MAPK3/1 kinase 1 and 2 [MAP2K1/2] inhibitor), or LY294002 (a selective phosphatidylinositol 3 kinase [PI3K] inhibitor) but not by phenyl-4,4,5,5 tetramethylimidazoline-1-oxyl 3-oxide (PTIO, a potent extracellular NO scavenger). At the maximal inhibitory dose without cytotoxicity, PD98059 and LY294002 completely inhibited VEGF-induced cell proliferation but only partially attenuated (P < 0.05) FGF2-induced cell proliferation. PD98059 and LY294002 also inhibited (P < 0.05) FGF2- and VEGF-induced phosphorylation of MAPK3/1 and AKT1, respectively. L-NMMA did not significantly affect FGF2- and VEGF-induced phosphorylation of either MAPK3/1 or AKT1. Thus, in OFPAE cells, both FGF2- and VEGF-stimulated cell proliferation is partly mediated via NO as an intracellular and downstream signal of MAPK3/1 and AKT1 activation. Moreover, activation of both MAP2K1/2/MAPK3/1 and PI3K/AKT1 pathways is critical for FGF2-stimulated cell proliferation, whereas activation of either one pathway is sufficient for mediating the VEGF-induced maximal cell proliferation, indicating that these two kinase pathways differentially mediate the FGF2- and VEGF-stimulated OFPAE cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901071      PMCID: PMC2441762          DOI: 10.1095/biolreprod.107.064477

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  40 in total

1.  Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells.

Authors:  H Sheng; J Shao; R N DuBois
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

2.  Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells.

Authors:  H P Reusch; S Zimmermann; M Schaefer; M Paul; K Moelling
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.

Authors:  B Souttou; D Raulais; M Vigny
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

4.  Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.

Authors:  A Zubilewicz; C Hecquet; J C Jeanny; G Soubrane; Y Courtois; F Mascarelli
Journal:  Oncogene       Date:  2001-03-22       Impact factor: 9.867

5.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.

Authors:  D Fukumura; T Gohongi; A Kadambi; Y Izumi; J Ang; C O Yun; D G Buerk; P L Huang; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.

Authors:  R Yashima; M Abe; K Tanaka; H Ueno; K Shitara; S Takenoshita; Y Sato
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

7.  Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.

Authors:  Kerstin Eriksson; Peetra Magnusson; Johan Dixelius; Lena Claesson-Welsh; Michael J Cross
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

8.  Regulation of Raf-Akt Cross-talk.

Authors:  Karin Moelling; Karen Schad; Magnus Bosse; Sven Zimmermann; Marc Schweneker
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

9.  Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.

Authors:  Tsunetatsu Namba; Hiromi Koike; Kazushi Murakami; Motokuni Aoki; Hirofumi Makino; Naotaka Hashiya; Toshio Ogihara; Yasufumi Kaneda; Masakazu Kohno; Ryuichi Morishita
Journal:  Circulation       Date:  2003-10-20       Impact factor: 29.690

10.  Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.

Authors:  Koh Kawasaki; Robert S Smith; Chung-Ming Hsieh; Jianxin Sun; Julie Chao; James K Liao
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more
  20 in total

1.  Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.

Authors:  Lin Feng; Wu-Xiang Liao; Quan Luo; Hong-Hai Zhang; Wen Wang; Jing Zheng; Dong-Bao Chen
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 2.  Signaling regulation of fetoplacental angiogenesis.

Authors:  Kai Wang; Jing Zheng
Journal:  J Endocrinol       Date:  2011-11-21       Impact factor: 4.286

3.  Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric-oxide synthase expression in placental artery endothelial cells.

Authors:  Eugenia Mata-Greenwood; Wu-xiang Liao; Wen Wang; Jing Zheng; Dong-bao Chen
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

Review 4.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

5.  Transcriptional and functional adaptations of human endothelial cells to physiological chronic low oxygen.

Authors:  Yi-Zhou Jiang; Kai Wang; Yan Li; Cai-Feng Dai; Ping Wang; Christina Kendziorski; Dong-Bao Chen; Jing Zheng
Journal:  Biol Reprod       Date:  2013-05-09       Impact factor: 4.285

6.  Suppression of protein phosphatase 2 differentially modulates VEGF- and FGF2-induced signaling in ovine fetoplacental artery endothelial cells.

Authors:  Y Song; K Wang; D-B Chen; R R Magness; J Zheng
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

7.  Differential activation of multiple signalling pathways dictates eNOS upregulation by FGF2 but not VEGF in placental artery endothelial cells.

Authors:  Eugenia Mata-Greenwood; Wu-Xiang Liao; Jing Zheng; Dong-Bao Chen
Journal:  Placenta       Date:  2008-06-20       Impact factor: 3.481

8.  Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.

Authors:  K Wang; Y-z Jiang; D-b Chen; J Zheng
Journal:  Placenta       Date:  2009-11-05       Impact factor: 3.481

Review 9.  Regulation of placental angiogenesis.

Authors:  Dong-Bao Chen; Jing Zheng
Journal:  Microcirculation       Date:  2014-01       Impact factor: 2.628

10.  Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells.

Authors:  Kai Wang; Yang Song; Dong-Bao Chen; Jing Zheng
Journal:  Biol Reprod       Date:  2008-05-28       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.